title: Sarcoidosis associated with vemurafenib.
authors.forename: A
authors.initials: A
authors.lastname: Adam
authors.forename: L
authors.initials: L
authors.lastname: Thomas
authors.forename: N
authors.initials: N
authors.lastname: Bories
authors.forename: D
authors.initials: D
authors.lastname: Zaharia
authors.forename: B
authors.initials: B
authors.lastname: Balme
authors.forename: N
authors.initials: N
authors.lastname: Freymond
authors.forename: S
authors.initials: S
authors.lastname: Dalle
mesh_terms: D000328:Adult; D000368:Aged; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D012507:Sarcoidosis / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects*; D000077484:Vemurafenib
chemical_list: D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib
keywords: BRAF; melanoma; sarcoidosis; vemurafenib